Efficacy and safety of palbociclib in patients with estrogen receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer with preexisting conditions: A post hoc analysis of PALOMA-2 - Gelmon, K; Walshe, JM; Mahtani, R (Breast, 2021)